Characterization of Unintentional Deaths Among Buprenorphine Users

Original research
by
Dai, Zhen et al

Release Date

2023

Geography

USA

Language of Resource

English

Full Text Available

No

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

This study sought to examine buprenorphine-involved deaths (BIDs) and compare them with other drug-related deaths.

Findings/Key points

Despite increasing buprenorphine use, BIDs comprised less than 5% of overall West Virginia drug-related deaths. Seldom was it the only drug found, and most decedents did not have current prescriptions for buprenorphine. Although buprenorphine is effective, with a wide safety margin, clinicians and patients should be aware that buprenorphine can be involved in overdose deaths, especially when buprenorphine is taken in combination with drugs such as benzodiazepines, methamphetamine, or fentanyl, and in persons with underlying cardiovascular or pulmonary comorbidities.

Design/methods

Analyzed West Virginia drug-related deaths from 2005 to early 2020 (11,764)

Keywords

Substitution/OAT
Mortality